Standardizing caloric restriction for preclinical cancer research.

Despite increasing rates of metabolic syndrome, cancer treatment regimens often ignore the underlying metabolic dysfunction in patients. A high proportion of cancer patients have metabolic dysfunction, and caloric restriction has shown the potential…

Preview only. Read the full abstract at the source